Published in Nature Medicine, investigators have combined two hormones that hold the potential for a new treatment option.
Tiny regulators produced by one of seven human cancer viruses may be the key to understanding the most common AIDS-associated malignancy.
Northwestern’s Center for Device Development is bringing together clinicians and engineers to develop medical devices with guidance from entrepreneurial experts and through a series of real-world experiences.
New Northwestern Medicine research is believed to have uncovered a novel therapeutic target for the number one genetic killer of toddlers in the developed world. Yong-Chao Ma, PhD, assistant professor in pediatrics, neurology, and physiology, is also working to uncover the potential of a new target in the fight against Parkinson’s disease.
Started by Dean Eric G. Neilson, MD, the annual luncheon celebrating Feinberg’s endowed professors serves as a way to thank and honor these faculty members for their accomplishments and contributions to science, education, and research.
Jonathan Chou, a third-year medical student, received a $30,000 grant from Research to Prevent Blindness that will enable him to take a year off from medical school to study the deterioration of eyesight in diabetics.
An innovative year-long pilot program has laid the foundation for training focused on elevating community-engaged research teams to the level of National Institutes of Health funding.
Northwestern Medicine researchers developed a new method to predict an individual patient’s brain tumor growth. This growth forecast will enable physicians to quickly identify how well the tumor is responding to a particular therapy.
A new study by C. Shad Thaxton, MD, and Leo Gordon, MD, shows that synthetic HDL nanoparticles killed B-cell lymphoma, the most common form of the disease, in cultured human cells.